The Medicines Discovery Catapult has appointed Dr Peter Simpson as Chief Scientific Officer, following a successful executive search conducted by The RSA Group.

Dr Andy Theodorou of The RSA Group commented “We are delighted to have been able to support and advise The Medicines Discovery Catapult in this key addition to their senior management team.  We extend our best wishes to Dr Simpson as he leads scientific strategy and collaborative projects at the MDC.”

Read the full release here:

Share this: